A 17-point quiz may reveal which older cancer patients need extra care

NCT ID NCT07773285

NEW Not yet recruiting Knowledge-focused Sponsor: Latin American Cooperative Oncology Group Source: ClinicalTrials.gov ↗

First seen Aug 19, 2026 · Last updated Aug 19, 2026

Summary

This study evaluates whether the G8 screening tool can accurately identify frailty and predict early death in adults aged 70 and older who are newly diagnosed with solid tumors. Researchers will assess 250 participants via phone or video calls, using a comprehensive geriatric assessment as the reference standard. The goal is to see if this quick, simple tool can help guide care for older cancer patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If the G8 tool proves reliable, doctors could quickly identify older cancer patients who need extra support, potentially improving care and outcomes.
What could go wrong: This is an observational study, so it cannot prove that using G8 improves survival. The tool's accuracy may vary across different populations and settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic malignant neoplasm Neoplasm Metastasis Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC SOLID TUMOR RECURRENT SOLID TUMOR SOLID TUMOR

Contacts and locations

Locations

HCOR - Hospital do Coração

São Paulo, São Paulo, 04004-030, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.